SCHEMBL889136

SCHEMBL889136

CCCNC(=O)CCN(CCC)CCC(=O)NCCC

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MCL1 Q07820 1/20 0.48
DNM1 Q05193 2/20 0.46
FAAH O00519 3/20 0.44
CASP2 P42575 1/20 0.44
CNR1 P21554 1/20 0.42
NAAA Q02083 1/20 0.41
TERT O14746 1/20 0.41
GAA P10253 2/20 0.38
KMT2A Q03164 2/20 0.38
ICMT O60725 1/20 0.38
ALB P02768 1/20 0.38
KDM4E B2RXH2 1/20 0.38
ALOX15 P16050 1/20 0.38
HSD17B10 Q99714 1/20 0.38
DRD2 P14416 1/20 0.38
MMP1 P03956 1/20 0.38
MMP2 P08253 1/20 0.38
MMP3 P08254 1/20 0.38
MMP9 P14780 1/20 0.38
MEN1 O00255 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17453102 0.96 DNM1 (0.47) MCL1DNM1FAAHCASP2CNR1
SCHEMBL16995712 0.93 MCL1 (0.43) MCL1DNM1FAAHCASP2CNR1
SCHEMBL24436199 0.91 MCL1 (0.42) MCL1DNM1FAAHCASP2CNR1
SCHEMBL889191 0.90 DNM1 (0.49) MCL1DNM1FAAHCASP2CNR1
SCHEMBL19726631 0.90 DNM1 (0.49) MCL1DNM1FAAHCASP2CNR1
SCHEMBL16995711 0.89 DNM1 (0.42) MCL1DNM1FAAHCASP2CNR1
SCHEMBL17453099 0.89 DNM1 (0.42) MCL1DNM1FAAHCASP2CNR1
SCHEMBL18346555 0.89 DNM1 (0.42) MCL1DNM1FAAHCASP2CNR1
SCHEMBL16995716 0.89 DNM1 (0.42) MCL1DNM1FAAHCASP2CNR1
SCHEMBL17453156 0.89 DNM1 (0.42) MCL1DNM1FAAHCASP2CNR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170312363-A1 MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR XIAMEN SINOPEG BIOTECH CO., LTD. (CN) 2017-11-02 US disclosed
US-20160015823-A1 PEPTIDE-DENDRIMER CONJUGATES AND USES THEREOF ANGIOCHEM INC. (CA) 2016-01-21 US disclosed
US-20120009222-A1 MODULATION OF THE IMMUNE RESPONSE MASSACHUSETTS INSTITUTE OF TECHNOLOGY (US) 2012-01-12 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20120009222-A1 MODULATION OF THE IMMUNE RESPONSE FCGRT, MYD88, C3AR1 MCL1 1122/4885DNM1 4279/4885FAAH 858/4885
US-20160015823-A1 PEPTIDE-DENDRIMER CONJUGATES AND USES THEREOF LRP6, LDLR, SELPLG MCL1 381/4885DNM1 139/4885FAAH 4561/4885
US-20170312363-A1 MULTIFUNCTIONALIZED POLYETHYLENE GLYCOL DERIVATIVE AND PREPARATION METHOD THEREFOR HDGF, F11, F12 MCL1 2299/4885DNM1 2280/4885FAAH 1494/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.